| Period Ending |
Dec 31, 2014 |
Sep 30, 2014 |
Jun 30, 2014 |
Mar 31, 2014 |
| Total Revenue |
1,127 |
1,372 |
803 |
400 |
| Cost of Revenue |
670 |
743 |
455 |
193 |
|
| Gross Profit |
457 |
628 |
349 |
207 |
|
|
Operating Expenses |
|
Research Development |
– |
– |
– |
– |
|
Selling General and Administrative |
647 |
583 |
751 |
233 |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
– |
– |
– |
– |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
| Operating Income or Loss |
(190) |
45 |
(403) |
(27) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
– |
– |
– |
– |
|
Earnings Before Interest And Taxes |
(190) |
45 |
(409) |
3 |
|
Interest Expense |
– |
– |
11 |
– |
|
Income Before Tax |
(190) |
45 |
(420) |
3 |
|
Income Tax Expense |
– |
1 |
– |
7 |
|
Minority Interest |
– |
– |
– |
– |
|
|
|
Net Income From Continuing Ops |
(190) |
44 |
(420) |
(4) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
| Net Income |
(190) |
44 |
(420) |
(4) |
| Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
| Net Income Applicable To Common Shares |
(190) |
44 |
(420) |
(4) |
|